253 related articles for article (PubMed ID: 21705125)
1. Aldosterone-induced fibrosis in the kidney: questions and controversies.
Brem AS; Morris DJ; Gong R
Am J Kidney Dis; 2011 Sep; 58(3):471-9. PubMed ID: 21705125
[TBL] [Abstract][Full Text] [Related]
2. Mineralocorticoid receptor activation and mineralocorticoid receptor antagonist treatment in cardiac and renal diseases.
Bauersachs J; Jaisser F; Toto R
Hypertension; 2015 Feb; 65(2):257-63. PubMed ID: 25368026
[No Abstract] [Full Text] [Related]
3. Prenatal overexposure to glucocorticoids programs renal 11β-hydroxysteroid dehydrogenase type 2 expression and salt-sensitive hypertension in the rat.
Tang JI; Kenyon CJ; Seckl JR; Nyirenda MJ
J Hypertens; 2011 Feb; 29(2):282-9. PubMed ID: 21045727
[TBL] [Abstract][Full Text] [Related]
4. Targeting activated mineralocorticoid receptor: Occam's razor revisited.
Brem AS
Kidney Int; 2012 Sep; 82(6):619-20. PubMed ID: 22935878
[TBL] [Abstract][Full Text] [Related]
5. Glucocorticoids and 11β-hydroxysteroid dehydrogenases: mechanisms for hypertension.
Hunter RW; Bailey MA
Curr Opin Pharmacol; 2015 Apr; 21():105-14. PubMed ID: 25666420
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of tissue repair by spironolactone: role of mineralocorticoids in fibrous tissue formation.
Slight SH; Chilakamarri VK; Nasr S; Dhalla AK; Ramires FJ; Sun Y; Ganjam VK; Weber KT
Mol Cell Biochem; 1998 Dec; 189(1-2):47-54. PubMed ID: 9879653
[TBL] [Abstract][Full Text] [Related]
7. Aldosterone and mineralocorticoid receptors: orphan questions.
Funder JW
Kidney Int; 2000 Apr; 57(4):1358-63. PubMed ID: 10760067
[TBL] [Abstract][Full Text] [Related]
8. Aldosterone and Mineralocorticoid Receptors-Physiology and Pathophysiology.
Funder JW
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28492512
[TBL] [Abstract][Full Text] [Related]
9. Multiple aspects of mineralocorticoid selectivity.
Farman N; Rafestin-Oblin ME
Am J Physiol Renal Physiol; 2001 Feb; 280(2):F181-92. PubMed ID: 11208593
[TBL] [Abstract][Full Text] [Related]
10. This is not Dr. Conn's aldosterone anymore.
Brown NJ
Trans Am Clin Climatol Assoc; 2011; 122():229-43. PubMed ID: 21686229
[TBL] [Abstract][Full Text] [Related]
11. Glucocorticoid-mediated mineralocorticoid receptor activation and hypertension.
Frey FJ; Odermatt A; Frey BM
Curr Opin Nephrol Hypertens; 2004 Jul; 13(4):451-8. PubMed ID: 15199296
[TBL] [Abstract][Full Text] [Related]
12. Transgenic model of aldosterone-driven cardiac hypertrophy and heart failure.
Qin W; Rudolph AE; Bond BR; Rocha R; Blomme EA; Goellner JJ; Funder JW; McMahon EG
Circ Res; 2003 Jul; 93(1):69-76. PubMed ID: 12791709
[TBL] [Abstract][Full Text] [Related]
13. 11beta-Hydroxysteroid dehydrogenase in the brain: a novel regulator of glucocorticoid action?
Seckl JR
Front Neuroendocrinol; 1997 Jan; 18(1):49-99. PubMed ID: 9000459
[TBL] [Abstract][Full Text] [Related]
14. Aldosterone deficiency and mineralocorticoid receptor antagonism prevent angiotensin II-induced cardiac, renal, and vascular injury.
Luther JM; Luo P; Wang Z; Cohen SE; Kim HS; Fogo AB; Brown NJ
Kidney Int; 2012 Sep; 82(6):643-51. PubMed ID: 22622494
[TBL] [Abstract][Full Text] [Related]
15. Aldosterone, salt and cardiac fibrosis.
Funder JW
Clin Exp Hypertens; 1997; 19(5-6):885-99. PubMed ID: 9247762
[TBL] [Abstract][Full Text] [Related]
16. Interactions of mineralocorticoids and glucocorticoids in epithelial target tissues revisited.
Morris DJ; Latif SA; Brem AS
Steroids; 2009 Jan; 74(1):1-6. PubMed ID: 19013186
[TBL] [Abstract][Full Text] [Related]
17. Renal sodium retention in cirrhotic rats depends on glucocorticoid-mediated activation of mineralocorticoid receptor due to decreased renal 11beta-HSD-2 activity.
Thiesson HC; Jensen BL; Bistrup C; Ottosen PD; McNeilly AD; Andrew R; Seckl J; Skøtt O
Am J Physiol Regul Integr Comp Physiol; 2007 Jan; 292(1):R625-36. PubMed ID: 16917017
[TBL] [Abstract][Full Text] [Related]
18. Mineralocorticoid receptors: distribution and activation.
Funder JW
Heart Fail Rev; 2005 Jan; 10(1):15-22. PubMed ID: 15947887
[TBL] [Abstract][Full Text] [Related]
19. 11beta-hydroxysteroid dehydrogenase type 2 activity in hypothalamic paraventricular nucleus modulates sympathetic excitation.
Zhang ZH; Kang YM; Yu Y; Wei SG; Schmidt TJ; Johnson AK; Felder RB
Hypertension; 2006 Jul; 48(1):127-33. PubMed ID: 16717146
[TBL] [Abstract][Full Text] [Related]
20. Pathophysiological roles of aldosterone and mineralocorticoid receptor in the kidney.
Rafiq K; Hitomi H; Nakano D; Nishiyama A
J Pharmacol Sci; 2011; 115(1):1-7. PubMed ID: 21186336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
